During the past decade, University Hospital Pilsen conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Pilsen" #1 sponsor was "Population Health Research Institute" with 2 trials, followed by "Charles University, Czech Republic" with 1 trials sponsored, "Czech Lymphoma Study Group" with 1 trials sponsored, "European Myeloma Network" with 1 trials sponsored and "European Society for Blood and Marrow Transplantation" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Pilsen" #1 collaborator was "University Hospital Pilsen" with 3 trials as a collaborator, "Charles University, Czech Republic" with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Ankara University" with 1 trials as a collaborator and "Brno University Hospital" with 1 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Pilsen" are "Cardiogenic Shock" (2 trials), "ST Elevation Myocardial Infarction" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Myocardial Infarction" (1 trials) and "Aplastic Anaemia" (1 trials). Many other conditions were trialed in "University Hospital Pilsen" in a lesser frequency.

Most popular intervention types in "University Hospital Pilsen" are "Drug" (6 trials), "Procedure" (3 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Access site in primary PCI" (1 trials), "Cangrelor" (1 trials), "Coronary Artery Bypass Graft with the use of CPB" (1 trials), "Coronary Artery Bypass Graft without the use of CPB" (1 trials) and "DNA testing" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Pilsen" are 11 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital Pilsen". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in University Hospital Pilsen, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Pilsen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".